Lab Tests & Genetic Testing: Understanding Your Child's Report
At a Glance
Familial hypomagnesemia with secondary hypocalcemia is supported by profoundly low magnesium, low calcium, and low or inappropriately normal PTH. A low FEMg suggests the kidneys are conserving magnesium, while two pathogenic or likely pathogenic TRPM6 variants can confirm the inherited diagnosis.
Navigating the laboratory and genetic reports for Familial hypomagnesemia with secondary hypocalcemia (HSH) can feel like learning a new language. These reports provide the evidence needed to distinguish HSH from more common conditions like epilepsy or primary parathyroid disorders. To confirm a diagnosis of HSH, doctors look for a specific “fingerprint” in the blood, urine, and DNA [1][2].
The Biochemical Profile of HSH
When a child has untreated HSH, their blood work typically shows a very specific pattern. Understanding these markers helps explain why the body is struggling. However, clinicians must interpret these together, as no single test is perfect:
- Magnesium (Mg): In HSH, magnesium is “profoundly” low [2]. This is the primary driver of all other symptoms.
- Calcium (Ca): This is also low, which is why HSH is often misdiagnosed as a calcium disorder [1][3].
- Parathyroid Hormone (PTH): This hormone is usually low or “inappropriately normal” [1]. Normally, when calcium is low, PTH should be very high to fix it. In HSH, the low magnesium prevents the body from making or responding to PTH [4].
- Phosphorus (Phos): This is typically normal or slightly high, which helps differentiate HSH from other bone-related disorders [1].
- Vitamin D: Levels of 25-hydroxyvitamin D are usually normal or even high, ruling out nutritional rickets as the primary cause [1].
The FEMg Test: Checking the Kidneys
One of the most important tools in an HSH diagnosis is the Fractional Excretion of Magnesium (FEMg). This is not a single blood test but a calculation that compares the amount of magnesium in the blood to the amount being lost in the urine [5].
To get an accurate result, doctors must collect a blood sample and a urine sample at the same time. In a child with severe magnesium deficiency from HSH, the kidneys are working perfectly—they see the body is starving for magnesium and try to save every bit of it. Therefore, the FEMg in an HSH patient is typically 2% or lower [2][1].
- If FEMg is <= 2%: This indicates the magnesium is being conserved by the kidneys, supporting an extrarenal loss like the gut [2].
- If FEMg is > 4%: This suggests the kidneys are “wasting” magnesium, which points toward a different genetic kidney condition rather than HSH [6].
Clinical Caveat: A low FEMg mainly shows that the kidneys are conserving magnesium and does not by itself establish HSH. Interpretation depends on age, kidney function, and other clinical context, requiring cautious clinician interpretation.
Genetic Testing: The Definitive Answer
While blood and urine tests point to HSH, genetic testing of the TRPM6 gene provides the final confirmation. Because HSH is an autosomal recessive condition, the report must ideally show two pathogenic or likely pathogenic mutations (one from each parent) [7][8].
Types of Genetic Analysis
Standard genetic “sequencing” (reading the DNA code like a book) is the first step, but it doesn’t always catch everything. A complete report should consider:
- Sequencing: Looks for “spelling errors” in the 39 sections (exons) of the TRPM6 gene [9].
- Deletion/Duplication Analysis (MLPA): This looks for missing “pages” or “chapters” of the gene. Some children have HSH because a large chunk of the gene is entirely absent, which standard sequencing can miss [4][10].
- Splice-Site Analysis: This checks the “punctuation” between the gene’s sections. If this is broken, the body cannot assemble the magnesium channel correctly [4][10].
Parental Segregation Testing
Once a mutation is found in the child, doctors often perform parental segregation testing [11]. This simply means testing both parents to ensure each one carries one of the child’s mutations. This confirms that the child inherited the condition “in trans” (one from mom and one from dad), which is the hallmark of a recessive genetic diagnosis [4][8]. A negative panel does not necessarily exclude HSH if the phenotype is strong, and a Variant of Uncertain Significance (VUS) requires further interpretation by a genetics professional.
Lab Report Completeness Checklist
Use this list to ensure your child has had a comprehensive diagnostic workup:
- [ ] Paired Blood and Urine: Were serum and urine magnesium/creatinine collected simultaneously?
- [ ] FEMg Calculation: Is the FEMg recorded? (Target for HSH is typically ≤2%) [2].
- [ ] Comprehensive Genetic Panel: Did the test include both sequencing and deletion/duplication analysis for the TRPM6 gene? [4].
- [ ] PTH Level: Was the Parathyroid Hormone level checked while calcium was low? [1].
- [ ] Kidney Function: Was creatinine or eGFR checked? (Kidney health affects how we interpret the FEMg) [12].
- [ ] Medication Review: Was the child taking any diuretics or other medications that could interfere with magnesium levels during testing? [13].
Common questions in this guide
What lab pattern is typical of familial hypomagnesemia with secondary hypocalcemia?
What does the FEMg result mean in a child being evaluated for HSH?
What should TRPM6 genetic testing include?
How many TRPM6 mutations are needed to support an HSH diagnosis?
Why might both parents have genetic testing after a child's result?
What should be included in a complete HSH lab workup?
Get notified when new evidence is published on Primary hypomagnesemia with secondary hypocalcemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Clinical Spectrum of Primary Hypomagnesemia with Secondary Hypocalcemia due to TRPM6 Mutation.
Aftab S, Anjum MN, Aslam N, et al.
Hormone research in paediatrics 2026; (99(7)):1045-1050 doi:10.1159/000547303.
PMID: 40853861 - 2
Three cases of hereditary hypomagnesemia with secondary hypocalcemia caused by novel TRPM6 gene mutations and a literature review.
Yang M, Zheng Z, Shan X, Luo Y
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(9)):917-925 doi:10.1515/jpem-2026-0185.
PMID: 42324811 - 3
Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6.
Astor MC, Løvås K, Wolff AS, et al.
Endocrine connections 2015; (4(4)):215-22 doi:10.1530/EC-15-0066.
PMID: 26273099 - 4
Case Report: A Novel Non-Canonical Splice Site Variant (c.1638+7T>C) in TRPM6 Cause Primary Homagnesemia With Secondary Hocalcemia.
Song J, Lei J, Zhang J, et al.
Frontiers in pediatrics 2022; (10()):834241 doi:10.3389/fped.2022.834241.
PMID: 35692977 - 5
The Effect of Omeprazole on Urinary Magnesium Excretion in Children with Peptic Diseases.
Famouri F, Tavahen N, Gholami H, et al.
Journal of research in pharmacy practice 2024; (13(2)):53-57 doi:10.4103/jrpp.jrpp_35_24.
PMID: 39830949 - 6
Utility of fractional excretion of magnesium in diagnosing renal magnesium wasting in pediatric nephrology practice.
Awazu M, Matsumura K
Clinical biochemistry 2024; (131-132()):110807 doi:10.1016/j.clinbiochem.2024.110807.
PMID: 39059606 - 7
Intestinal hypomagnesemia in an Iranian patient with a novel TRPM6 variant: a case report and review of the literature.
Kamali F, Jamee M, Sayer JA, et al.
CEN case reports 2023; (12(4)):413-418 doi:10.1007/s13730-023-00785-8.
PMID: 36967423 - 8
Case Report: Novel TRPM6 Mutations Cause Hereditary Hypomagnesemia With Secondary Hypocalcemia in a Chinese Family and a Literature Review.
Han Y, Zhao Y, Wang H, Huo L
Frontiers in pediatrics 2022; (10()):912524 doi:10.3389/fped.2022.912524.
PMID: 35903165 - 9
Long-term Clinical Follow-up of Patients with Familial Hypomagnesemia with Secondary Hypocalcemia
Bayramoğlu E, Keskin M, Aycan Z, et al.
Journal of clinical research in pediatric endocrinology 2021; (13(3)):300-307 doi:10.4274/jcrpe.galenos.2021.2020.0192.
PMID: 33565749 - 10
A functional study for verifying the pathogenicity of a TRPM6 variant of uncertain significance: A novel non-canonical splicing-site variant in primary hypomagnesemia with secondary hypocalcemia.
Wang P, Qian Y, Gu C, et al.
Clinica chimica acta; international journal of clinical chemistry 2021; (523()):469-475 doi:10.1016/j.cca.2021.10.033.
PMID: 34755648 - 11
Familial hypomagnesemia with secondary hypocalcemia: a novel TRPM6 mutation associated with treatment-resistant migraine in a North African family.
Paola PM, Gianni C, Emanuele M, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(10)).
PMID: 42830330 - 12
Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease.
Grigore TV, Zuidscherwoude M, Witasp A, et al.
Frontiers in endocrinology 2022; (13()):1046392 doi:10.3389/fendo.2022.1046392.
PMID: 36699036 - 13
Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.
Ledeganck KJ, Anné C, De Monie A, et al.
Nutrients 2018; (10(6)) doi:10.3390/nu10060677.
PMID: 29861470
This page is for informational purposes only and does not constitute medical advice. Your child's healthcare team should interpret the laboratory and genetic results in the context of their care.